166 related articles for article (PubMed ID: 37498395)
1. Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study.
Jiang T; Sun H; Li N; Jiang T
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13511-13521. PubMed ID: 37498395
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
Song Z; Zou L
Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
[TBL] [Abstract][Full Text] [Related]
3. [Development and Validation of A Prognostic Nomogram to Guide Decision-making
in Lung Large Cell Neuroendocrine Carcinoma].
Chen S; Li S; Wang Z; Zhang W; Zhou L; Jiao W
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):487-496. PubMed ID: 37653012
[TBL] [Abstract][Full Text] [Related]
4. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis.
Chen X; Huang Y; Chen F; She H; Chen X
Cancer Med; 2023 Feb; 12(4):4087-4099. PubMed ID: 36125491
[TBL] [Abstract][Full Text] [Related]
6. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and predictive models for patients with lung large cell neuroendocrine carcinoma: Based on SEER database.
Li W; Huang Q; He X; He Q; Lai Q; Yuan Q; Deng Z
Clin Respir J; 2024 Apr; 18(4):e13752. PubMed ID: 38606731
[TBL] [Abstract][Full Text] [Related]
8. Double-edged role of radiotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Jiang Y; Lei C; Zhang X; Cui Y; Che K; Shen H
J Cancer; 2019; 10(25):6422-6430. PubMed ID: 31772675
[No Abstract] [Full Text] [Related]
9. Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma.
Yang Y; Shen C; Shao J; Wang Y; Wang G; Shen A
Front Oncol; 2022; 12():825598. PubMed ID: 35847910
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma.
Xi J; Zhao M; Zheng Y; Liang J; Hu Z; Huang Y; Yang Y; Zhan C; Jiang W; Lu T; Guo W; Wang Q
Transl Cancer Res; 2020 Aug; 9(8):4943-4957. PubMed ID: 35117856
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
[TBL] [Abstract][Full Text] [Related]
12. The prognosis analysis of organ metastatic patterns in lung large cell neuroendocrine carcinoma: A population-based study.
Chen K; Dai P; Ni J; Xiang Y; Gu L
Front Oncol; 2022; 12():1050800. PubMed ID: 36568210
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.
Huang G; Liao J; Cai S; Chen Z; Qin X; Ba L; Rao J; Zhong W; Lin Y; Liang Y; Wei L; Li J; Deng K; Li X; Guo Z; Wang L; Zhuo Y
Front Oncol; 2022; 12():949058. PubMed ID: 36237316
[TBL] [Abstract][Full Text] [Related]
14. Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study.
Mu X; Pu D; Zhu Y; Zhou Y; Wu Q; Liu Q; Yin L; Li Y
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373819
[TBL] [Abstract][Full Text] [Related]
15. A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma.
Zhang T; Mao Z; Ma M; Li G; Qiao X; Wang H
Transl Cancer Res; 2024 Feb; 13(2):916-934. PubMed ID: 38482439
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis.
Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G
Front Oncol; 2022; 12():921365. PubMed ID: 36465408
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome and prognostic analysis of advanced large cell neuroendocrine carcinoma of the lung.
Xia L; Wang L; Zhou Z; Han S
Sci Rep; 2022 Oct; 12(1):16562. PubMed ID: 36195623
[TBL] [Abstract][Full Text] [Related]
19. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
20. Large-cell neuroendocrine carcinoma of the gynecologic tract: Prevalence, survival outcomes, and associated factors.
Pang L; Chen J; Chang X
Front Oncol; 2022; 12():970985. PubMed ID: 36457506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
